3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
3
Lymphoid
3
Plasma cell
2
Head & Neck
2
Gynecologic
2
Genitourinary
2
Other solid neoplasm
1
Other neoplasm
1
Other hematologic neoplasm
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Head and Neck Neoplasms
1
Agnosia
1
Interventions
Cisplatin
85
pembrolizumab
76
Magnetic Resonance Spectroscopy
46
Radiotherapy, Intensity-Modulated
41
Specimen Handling
36
Cetuximab
36
Carboplatin
35
Radiotherapy
34
Nivolumab
28
Paclitaxel
24
Radiation
22
Platinum
22
Docetaxel
20
Biopsy
20
1,2-diaminocyclohexaneplatinum II citrate
20
Gemcitabine
19
Surveys and Questionnaires
15
Fluorouracil
14
toripalimab
13
Standard of Care
12
Taxes
11
cemiplimab
9
atezolizumab
9
Ipilimumab
9
Drug Therapy
9
Cyclophosphamide
9
X-Rays
8
Surgical Procedures, Operative
8
Radiosurgery
7
Immunoglobulin G
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Acetaminophen
×
Head & Neck
×
90 days
×
Clear all
NCT06992427
2026-05-11
HOPE
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
228 enrolled
NCT02439034
2026-03-16
KETOCOL
Centre Oscar Lambret
Phase 2
Completed
68 enrolled